Genomics

Dataset Information

0

Temporal evolution of cellular heterogeneity during the progression to advanced, AR-negative prostate cancer [ChIP-seq]


ABSTRACT: Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance ultimately ensues. A significant subset of patients with resistant disease develop AR-null, androgen-indifferent tumors that lose their luminal identify and display neuroendocrine features (neuroendocrine prostate cancer (NEPC)). Utilizing a genetically engineered mouse model, we have characterized the synergy between N-Myc overexpression and RB1 loss-of-function which results in the formation of AR-negative, poorly differentiated tumors with high metastatic potential. Single-cell-based approaches revealed striking changes to the transcriptome and chromatin accessibility during the transition to NEPC. Global DNA methylation and the N-Myc cistrome are redirected following RB1 loss. Altogether, our data provide new insight into the progression to NEPC.

ORGANISM(S): Mus musculus

PROVIDER: GSE151424 | GEO | 2021/04/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-04-07 | GSE158468 | GEO
2021-04-07 | GSE158467 | GEO
2021-04-07 | GSE151581 | GEO
2021-04-07 | GSE151425 | GEO
2024-08-28 | GSE264598 | GEO
2020-05-29 | PXD012970 | Pride
2020-05-29 | PXD012971 | Pride
2019-08-26 | GSE117305 | GEO
2019-08-26 | GSE117304 | GEO
2024-01-02 | GSE151433 | GEO